Skip to main content

Publications

Learn more about the work that we do in the Wong Lab through our recent publications. For all publications, visit PubMed. 

Featured Publication

Illustration showing a TET2-mutant blood cell clone activating NLRP3 inflammatory signaling and releasing cytokines associated with liver disease.

In a study published in Nature, we show that clonal hematopoiesis increases the risk of chronic liver disease by promoting NLRP3-dependent inflammation.

Read the study

Recent Publications

  1. Wu SJ, Hergott CB, Griffin GK, Lane AA, Luskin MR, Larocca CA, LeBoeuf NR, Matsumoto NP, Shimony S, Waller BF  et al.  The Clinicopathologic and Genomic Features of Mature Versus Blastic Plasmacytoid Dendritic Cell Neoplasms Arising From Chronic Myeloid Neoplasms.  Am J Surg Pathol  2026 Aug 01;50(8):872-882. doi:10.1097/PAS.0000000000002556
  2. Wong WJ, Zon RL, Gibson CJ, Ho C, Pozdnyakova O, Neuberg D, Battinelli EM, Luskin MR, Tothova Z, Morgan EA  et al.  Somatic mutations in STAG2 are associated with separated megakaryocyte nuclear lobes in myelodysplastic syndromes.  Blood Adv  2025 Oct 28;9(20):5283-5288. doi:10.1182/bloodadvances.2025016897
  3. Liu A, Nayak L, Wong WJ, Ahn IE, Murakami N  Masked Arginine Vasopressin Deficiency in a Kidney Transplant Recipient With Posttransplant Lymphoproliferative Disorder.  Kidney Int Rep  2024 Sep;9(9):2832-2834. doi:10.1016/j.ekir.2024.06.029
  4. Lin AE, Bapat AC, Xiao L, Niroula A, Ye J, Wong WJ, Agrawal M, Farady CJ, Boettcher A, Hergott CB  et al.  Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation.  Circulation  2024 Apr 30;149(18):1419-1434. doi:10.1161/CIRCULATIONAHA.123.065597
  5. Ahmad MH, Hegde M, Wong WJ, Mohammadhosseini M, Garrett L, Carrascoso A, Issac N, Ebert B, Silva JC, Pihan G  et al.  Runx1-R188Q germ line mutation induces inflammation and predisposition to hematologic malignancies in mice.  Blood Adv  2023 Dec 12;7(23):7304-7318. doi:10.1182/bloodadvances.2023010398
  6. Belizaire R, Wong WJ, Robinette ML, Ebert BL  Clonal haematopoiesis and dysregulation of the immune system.  Nat Rev Immunol  2023 Sep;23(9):595-610. doi:10.1038/s41577-023-00843-3
  7. Wong WJ, Emdin C, Bick AG, Zekavat SM, Niroula A, Pirruccello JP, Dichtel L, Griffin G, Uddin MM, Gibson CJ  et al.  Author Correction: Clonal haematopoiesis and risk of chronic liver disease.  Nature  2023 Jul;619(7970):E47. doi:10.1038/s41586-023-06375-z
  8. Weeks LD, Niroula A, Neuberg D, Wong W, Lindsley RC, Luskin M, Berliner N, Stone RM, DeAngelo DJ, Soiffer R  et al.  Prediction of risk for myeloid malignancy in clonal hematopoiesis.  NEJM Evid  2023 May;2(5). doi:10.1056/evidoa2200310
  9. Wong WJ, Emdin C, Bick AG, Zekavat SM, Niroula A, Pirruccello JP, Dichtel L, Griffin G, Uddin MM, Gibson CJ  et al.  Clonal haematopoiesis and risk of chronic liver disease.  Nature  2023 Apr;616(7958):747-754. doi:10.1038/s41586-023-05857-4
  10. Agrawal M, Niroula A, Cunin P, McConkey M, Shkolnik V, Kim PG, Wong WJ, Weeks LD, Lin AE, Miller PG  et al.  TET2-mutant clonal hematopoiesis and risk of gout.  Blood  2022 Sep 08;140(10):1094-1103. doi:10.1182/blood.2022015384
  11. Vining KH, Marneth AE, Adu-Berchie K, Grolman JM, Tringides CM, Liu Y, Wong WJ, Pozdnyakova O, Severgnini M, Stafford A  et al.  Mechanical checkpoint regulates monocyte differentiation in fibrotic niches.  Nat Mater  2022 Aug;21(8):939-950. doi:10.1038/s41563-022-01293-3
  12. Goyal A, Narayanan D, Wong W, Laga AC, Connell NT, Ritter SY, Cobos G  Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome.  JAAD Case Rep  2022 May;23:15-19. doi:10.1016/j.jdcr.2022.02.022
  13. Evans MG, Crymes A, Crombie JL, Basu SS, Dillon DA, Wong WJ  Monotypic plasmacytoid cells mimicking lymph node malignancy in the setting of COVID-19 recovery.  Am J Hematol  2022 May;97(5):666-667. doi:10.1002/ajh.26408
  14. Kim PG, Niroula A, Shkolnik V, McConkey M, Lin AE, Słabicki M, Kemp JP, Bick A, Gibson CJ, Griffin G  et al.  Dnmt3a-mutated clonal hematopoiesis promotes osteoporosis.  J Exp Med  2021 Dec 06;218(12). pii:e20211872
  15. Niroula A, Sekar A, Murakami MA, Trinder M, Agrawal M, Wong WJ, Bick AG, Uddin MM, Gibson CJ, Griffin GK  et al.  Distinction of lymphoid and myeloid clonal hematopoiesis.  Nat Med  2021 Nov;27(11):1921-1927. doi:10.1038/s41591-021-01521-4
  16. Beauchamp EM, Leventhal M, Bernard E, Hoppe ER, Todisco G, Creignou M, Gallì A, Castellano CA, McConkey M, Tarun A  et al.  ZBTB33 is mutated in clonal hematopoiesis and myelodysplastic syndromes and impacts RNA splicing.  Blood Cancer Discov  2021 Sep;2(5):500-517. doi:10.1158/2643-3230.BCD-20-0224
  17. Miller PG, Sperling AS, Gibson CJ, Pozdnyakova O, Wong WJ, Manos MP, Buchbinder EI, Hodi FS, Ebert BL, Davids MS  A deep molecular response of splenic marginal zone lymphoma to front-line checkpoint blockade.  Haematologica  2021 Feb 01;106(2):651-654. doi:10.3324/haematol.2020.258426
  18. Boettcher S, Miller PG, Sharma R, McConkey M, Leventhal M, Krivtsov AV, Giacomelli AO, Wong W, Kim J, Chao S  et al.  A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies.  Science  2019 Aug 09;365(6453):599-604. doi:10.1126/science.aax3649
  19. Wong WJ, Ruhangaza D, Manirakiza A, Omondi J, Mugabe MC, Isabelle I, Morgan EA, Aster JC  Concomitant classic Hodgkin lymphoma and schistosomiasis.  Am J Hematol  2019 Jul;94(7):840-841. doi:10.1002/ajh.25316
  20. Patel SS, Ho C, Ptashkin RN, Sadigh S, Bagg A, Geyer JT, Xu ML, Prebet T, Mason EF, Seegmiller AC  et al.  Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms.  Blood Adv  2019 May 14;3(9):1540-1545. doi:10.1182/bloodadvances.2019000090
  21. Wong WJ, Baltay M, Getz A, Fuhrman K, Aster JC, Hasserjian RP, Pozdnyakova O  Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signatures.  PLoS One  2019;14(5):e0216810. pii:e0216810
  22. Wong WJ, Pozdnyakova O  Myeloproliferative neoplasms: Diagnostic workup of the cythemic patient.  Int J Lab Hematol  2019 May;41 Suppl 1:142-150. doi:10.1111/ijlh.13005
  23. Boiocchi L, Hasserjian RP, Pozdnyakova O, Wong WJ, Lennerz JK, Le LP, Dias-Santagata D, Iafrate AJ, Hobbs GS, Nardi V  Clinicopathological and molecular features of SF3B1-mutated myeloproliferative neoplasms.  Hum Pathol  2019 Apr;86:1-11. doi:10.1016/j.humpath.2018.11.022
  24. Wong WJ, Hasserjian RP, Pinkus GS, Breyfogle LJ, Mullally A, Pozdnyakova O  JAK2, CALR, MPL and ASXL1 mutational status correlates with distinct histological features in Philadelphia chromosome-negative myeloproliferative neoplasms.  Haematologica  2018 Feb;103(2):e63-e68. doi:10.3324/haematol.2017.178988
  25. Gade TPF, Tucker E, Nakazawa MS, Hunt SJ, Wong W, Krock B, Weber CN, Nadolski GJ, Clark TWI, Soulen MC  et al.  Ischemia Induces Quiescence and Autophagy Dependence in Hepatocellular Carcinoma.  Radiology  2017 Jun;283(3):702-710. doi:10.1148/radiol.2017160728
  26. Naunheim MR, Wong WJ, Carroll TL  Chalky Vocal Fold Lesions.  JAMA Otolaryngol Head Neck Surg  2017 Feb 01;143(2):185-186. doi:10.1001/jamaoto.2016.1819
  27. Wong WJ, Lauria A, Hornick JL, Xiao S, Fletcher JA, Marino-Enriquez A  Alternate PAX3-FOXO1 oncogenic fusion in biphenotypic sinonasal sarcoma.  Genes Chromosomes Cancer  2016 Jan;55(1):25-9. doi:10.1002/gcc.22295